|Year : 2017 | Volume
| Issue : 2 | Page : 162-166
Epidemiology of extrapulmonary and disseminated tuberculosis in a tertiary care center in Oman
Department of Medicine, Sultan Qaboos University Hospital, Sultanate of Oman, Oman
|Date of Web Publication||19-May-2017|
Department of Medicine, Sultan Qaboos University Hospital, Al-Khod, PO 123, Muscat
Source of Support: None, Conflict of Interest: None
Background: The incidence of extrapulmonary and disseminated tuberculosis (TB) cases is increasing worldwide, and this growth significantly impacts TB-related morbidity and mortality. Little is known about the host risk factors for extrapulmonary and disseminated TB. In this study, we examined those risk factors. Materials and Methods: We conducted a retrospective review of all TB cases admitted to Sultan Qaboos University Hospital from 2006 to 2015. We compared extrapulmonary TB (EPTB) cases with pulmonary and disseminated TB cases. We evaluated the risk factors associated with the development of extrapulmonary and disseminated TB using logistic regression analysis. Results: We reviewed 260 TB cases, of which EPTB comprised 37%, PTB comprised 53%, and disseminated TB comprised 10%. The most common sites of infection in the EPTB group were the lymph nodes and the abdomen. Disseminated TB and TB meningitis were more common in expatriates than in Omanis. Patients with EPTB were less likely to smoke compared to a patient with PTB. Patients with disseminated TB had a higher mortality when compared to patients with EPTB (adjusted odds ratio [OR], 0.004; 95% confidence intervals [CI]: 0.001–0.054;P = 0.001) and PTB (adjusted OR, 0.022; 95% CI: 0.004–0.115;P = 0.001). Human immunodeficiency virus (HIV) was the main risk factor for patients with disseminated TB when compared to patients with extrapulmonary and PTB. Conclusion: The rates of extrapulmonary and disseminated TB in Oman are higher than what has been recognized. Expatriates, patients with HIV, and smokers are at high risk for disseminated TB. In these patients, suspected extrapulmonary sites should be evaluated and sampled to exclude disseminated TB.
Keywords: Disseminated, epidemiology, extrapulmonary, Oman, predictors, tuberculosis
|How to cite this article:|
Gaifer Z. Epidemiology of extrapulmonary and disseminated tuberculosis in a tertiary care center in Oman. Int J Mycobacteriol 2017;6:162-6
|How to cite this URL:|
Gaifer Z. Epidemiology of extrapulmonary and disseminated tuberculosis in a tertiary care center in Oman. Int J Mycobacteriol [serial online] 2017 [cited 2020 Jun 1];6:162-6. Available from: http://www.ijmyco.org/text.asp?2017/6/2/162/206600
| Introduction|| |
Tuberculosis (TB) remains a major threat to humanity despite improvements in health-care systems and the widespread implementation of TB control programs. In 2015, the World Health Organization (WHO) estimated 10.4 million individuals had TB, but only 6 million cases had been reported to the WHO. Alarmingly, this means that more than half of all TB cases are unrecognized or unreported to the WHO. TB involving an organ other than the lung is known as extrapulmonary TB (EPTB). EPTB is one of the major reasons for underdiagnosis. TB is curable if recognized early and appropriately treated. However, the worldwide incidence of EPTB and disseminated TB cases (cases where pulmonary and EPTB are found in the same patient) are increasing and significantly contributing to TB-related morbidity and mortality.
While studies have suggested that EPTB and disseminated TB are common in immunocompromised patients, other risks factors are still unknown. Few studies of extrapulmonary and disseminated TB have been published recently, particularly in the Middle East and Gulf area population which significantly contribute to the global burden of TB.
In this retrospective study, we reviewed all TB cases admitted to a tertiary care center in Oman over a 10-year period from 2006 to 2015. We compared the demographics and clinical characteristics of extrapulmonary, pulmonary, and disseminated TB cases. The aim of this study is to enhance the understanding of the epidemiology of EPTB and disseminated TB by exploring the risk factors and common clinical presentations. These findings should improve the early detection of EPTB and disseminated TB cases.
| Materials and Methods|| |
We retrospectively reviewed TB cases seen at Sultan Qaboos University Hospital from August 2006 to December 2015. We included both Mycobacterium TB culture-positive and culture-negative cases. Culture-negative cases were included if they had clinical and histological findings suggestive of TB. We did not exclude any age groups. All data were gathered from the hospital's electronic medical records.
We used the WHO classification to categorize TB cases. PTB cases were composed of cases where the infection involved the lung parenchyma or the tracheobronchial tree. TB infections involving any other organs or intrathoracic lymph nodes or tuberculous pleural effusion without radiographic abnormalities in the lungs comprised cases of EPTB. Patients with both PTB and EPTB were classified as cases of disseminated TB. All 3 groups were compared to each other. Variables collected were age, sex, country of origin, living area, previous treatment for TB, immunosuppressive therapy, smoking, alcohol or drug use, and underlying clinical diseases such as chronic renal disease, chronic liver disease, malignancy, and human immunodeficiency virus (HIV). Immunosuppressive therapy was defined as receiving cytotoxic agents or corticosteroids for any period before the diagnosis of TB. Diabetes mellitus (DM) diagnosis was determined by documented history of DM. Any death before or during TB treatment was considered TB-related mortality.
Descriptive statistics were used to describe the data. We reported categorical variables using frequency and percentage, and we compared them using Chi-square test (or Fisher exact test when applicable). For normal distributed continuous variables, we used mean and standard deviation to present the data while analysis was performed using Student's t-tests. For nonnormal distributed continuous variables, median and interquartile range were used to summarize the data and analysis performed using Wilcoxon–Mann–Whitney tests. We evaluated the risk factors associated with the development of EPTB and disseminated TB by using Logistic regression model utilizing the backward stepwise selection procedure with a significance level of >0.2 for the removal from the model. A P < 0.05 was considered statistically significant. Odds ratios (OR) and their 95% confidence intervals (CI) were calculated to compare groups. StataCorp. 2011. Stata Statistical Software: Release 12. (StataCorp LP, College Station, TX, USA) was used for data analysis. This study was approved by the institutional review board of Sultan Qaboos University.
| Results|| |
We reviewed a total of 260 TB cases; the mean age was 41 ± 20 years, and males represented 60% of all TB cases. Omani comprised 90% of the cases, and 196 cases (75%) were TB-culture confirmed cases [Table 1]. There were 20 cases (7.7%) of HIV and 29 cases (15.4%) of DM. Death occurred in 36 TB cases (13.9%). Cancer diagnosis was found in 12 cases (16.7%) while 19 cases (7.3%) had been previously diagnosed with TB. EPTB, PTB, and disseminated TB cases represented 37%, 53%, and 10% of the total cases, respectively. The most common sites of infection in the EPTB group were the lymph nodes (42%), the abdomen (31%), brain (10%), musculoskeletal tissue (10%), and other sites (7%). Our subgroup analysis revealed TB meningitis was more common in expatriates than in Omani (OR: 11.5; 95% CI: 3.069–43.098; P = 0.001).
|Table 1: Demographic characteristics of tuberculosis cases stratified by site of infection to pulmonary, extra.pulmonary and disseminated tuberculosis|
Click here to view
Comparing EPTB with PTB cases, our unadjusted analysis [Table 2] revealed EPTB cases were more associated with female gender (unadjusted OR: 2.15; 95% CI: 1.259–3.670; P = 0.005), nonsmokers (OR: 0.246; 95% CI: 0.108–0.556; P = 0.001), lower mortality (OR: 0.262; 95% CI: 0.073–0.933; P= 0.028), and negative TB cultures (OR: 0.362; 95% CI: 0.193–0.679; P = 0.001). However, after adjusting for confounders in the multivariable logistic model, the only variables that remained significant were the smoking status (adjusted OR: 0.318; 95% CI: 0.131–0.770; P = 0.011) and negative TB culture (adjusted OR: 0.443; 95% CI: 0.229–0.858; P = 0.016).
|Table 2: Unadjusted and adjusted analysis for extrapulmonary compared to pulmonary tuberculosis|
Click here to view
[Table 3] shows our comparison of EPTB cases with disseminated TB. In our adjusted analysis, EPTB cases were less likely to be expatriates (adjusted OR: 0.078; 95% CI: 0.012–0.497; P = 0.007), less likely to be smokers (adjusted OR, 0.106; 95% CI: 0.011–0.962; P = 0.046), less likely to be HIV positive (adjusted OR: 0.047; 95% CI: 0.005–0.461; P = 0.009), and they had lower TB-related mortality (adjusted OR, 0.004; 95% CI: 0.001–0.054; P = 0.0001). Moreover, EPTB cases were more likely to have a culture positive than disseminated TB cases (adjusted OR: 6.348; 95% CI: 1.153–34.939; P = 0.034). In our unadjusted analysis, we found EPTB associated more with the female gender, but this association became insignificant in the adjusted analysis.
|Table 3: Unadjusted and adjusted analysis for extrapulmonary and disseminated tuberculosis (n=123)|
Click here to view
When we compared PTB with disseminated TB [Table 4]], we found PTB cases were more likely to be culture positive (adjusted OR: 6.720; 95% CI: 1.698–26.599; P = 0.007). However, they were less likely to be expatriates (adjusted OR: 0.069; 95% CI: 0.013–0.359; P = 0.001), HIV positive (adjusted OR: 0.171; 95% CI: 0.036–0.822; P = 0.027) and had lower TB-related mortality (adjusted OR: 0.022; 95% CI: 0.004–0.115; P = 0.0001). Smoking, as a variable, was not associated with PTB when compare with disseminated TB.
|Table 4: Unadjusted and adjusted analysis for pulmonary compared to disseminated tuberculosis (n=164)|
Click here to view
| Discussion|| |
Our study revealed higher rates of EPTB and disseminated TB compared to the rates estimated by the WHO in both Oman and other Gulf countries., This difference in the rates may be due to underreporting of TB cases to the national TB programs and WHO. Nevertheless, the rates reported in hospital-based TB studies are often more accurate than those reported by national surveillance TB programs. Our finding that lymph nodes and the abdomen were main sites for EPTB aligned with many other studies reporting the same.,
Our data suggest that disseminated and TB meningitis were both more in expatriates than in Omani. This could be due to the protective effect of the Bacillus Calmette–Guérin (BCG) vaccine common among Omanis. The BCG vaccine is known to decrease the risk of disseminated and TB meningitis when administered early in life,, and the BCG vaccination program in Oman is more well-established compared to the countries of origin of the expatriates in Oman. It may also be that the routine screening of expatriates for PTB on entry to the country may increase the number of EPTB cases relative to PTB cases.
The rate of HIV and TB coinfection was similar to the rates in other developed countries. We found no significant association between HIV infection and EPTB when compared with PTB. However, HIV infection was a significant risk factor for disseminated TB. This finding aligns with many studies, and it is rationalized by the negative effect of HIV on the immune system.
We found smoking is a risk factor for PTB and disseminated TB compared to EPTB, which concurs with other published studies. Smoking predisposes to a person to TB infection , and increases the risk of TB treatment failure. Several reports suggested that smoking can cause lung tissue destruction and suppress the lung immune response.,
Although the outcome of TB was not the primary focus of our study, when we compared PTB with EPTB, we found no significant different in the outcome. However, disseminated TB had higher mortality when compared to PTB and EPTB cases. This high risk of mortality in disseminated TB has been attributed to the late diagnosis of a TB infection, but disseminated TB often carries a worse prognosis as it is often associated with immune system dysfunction.
Our study has some limitations. We found no association between the site of TB infection and DM, chronic renal disease, chronic liver disease, malignancy, and prior immunosuppressive therapy. This could be due to underpowered variables in our study sample which led to an inability to detect a significant association. A larger sample-size study is necessary to provide more precise results. In addition, we may have underestimated the effects of HIV and DM on EPTB, given that HIV status was unknown in 6.5% of cases, and DM diagnosis was not based on serum glucose but medical record documentation. We expect the actual TB-related death incidence to be higher than what we have estimated because we lack TB outcomes after discharge from the hospital and after completion of TB therapy. Nonetheless, an assessment of TB outcomes during hospitalization reflects TB deaths that occurred before or during initial TB treatment which may indicate a severe infection or late TB diagnosis. A larger prospective study is required to overcome these limitations.
| Conclusion|| |
The rates of extrapulmonary and disseminated TB in Oman are higher than what has been recognized. Expatriates, patients with HIV, and smokers are at high risk for disseminated TB. In these patients, suspected extrapulmonary sites should be evaluated and sampled to exclude disseminated TB. Further studies are needed to identify the role of mycobacterial virulence factors and other host risk factors in the pathogenesis of disseminated and EPTB.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993;148:1292-7.
Memish ZA, Bamgboye EA, Abuljadayel N, Smadi H, Abouzeid MS, Al Hakeem RF. Incidence of and risk factors associated with pulmonary and extra-pulmonary tuberculosis in Saudi Arabia (2010-2011). PLoS One 2014;9:e95654.
Kruijshaar ME, Abubakar I. Increase in extrapulmonary tuberculosis in England and Wales 1999-2006. Thorax 2009;64:1090-5.
Sandgren A, Hollo V, van der Werf MJ. Extrapulmonary tuberculosis in the European Union and European Economic Area, 2002 to 2011. Euro Surveill 2013;18. pii: 20431.
Romanus V. Tuberculosis in Bacillus Calmette-Guérin-immunized and unimmunized children in Sweden: A ten-year evaluation following the cessation of general Bacillus Calmette-Guérin immunization of the newborn in 1975. Pediatr Infect Dis J 1987;6:272-80.
The use of preventive therapy for tuberculous infection in the United States. Recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR Recomm Rep 1990;39:9-12.
De Cock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992;268:1581-7.
Gonzalez OY, Adams G, Teeter LD, Bui TT, Musser JM, Graviss EA. Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis 2003;7:1178-85.
Maurya V, Vijayan VK, Shah A. Smoking and tuberculosis: An association overlooked. Int J Tuberc Lung Dis 2002;6:942-51.
Buskin SE, Gale JL, Weiss NS, Nolan CM. Tuberculosis risk factors in adults in King County, Washington, 1988 through 1990. Am J Public Health 1994;84:1750-6.
Chuang HC, Su CL, Liu HC, Feng PH, Lee KY, Chuang KJ, et al.
Cigarette smoke is a risk factor for severity and treatment outcome in patients with culture-positive tuberculosis. Ther Clin Risk Manag 2015;11:1539-44.
Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002;2:372-7.
Plit ML, Theron AJ, Fickl H, van Rensburg CE, Pendel S, Anderson R. Influence of antimicrobial chemotherapy and smoking status on the plasma concentrations of Vitamin C, Vitamin E, beta-carotene, acute phase reactants, iron and lipid peroxides in patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 1998;2:590-6.
Crump JA, Reller LB. Two decades of disseminated tuberculosis at a university medical center: The expanding role of mycobacterial blood culture. Clin Infect Dis 2003;37:1037-43.
[Table 1], [Table 2], [Table 3], [Table 4]
|This article has been cited by|
||Tuberculosis in people with rheumatic disease in Finland 1995–2007: a nationwide retrospective register study
| ||Marjo Vuorela,Nina J Mars,Juha Salonen,Markku J Kauppi |
| ||Rheumatology Advances in Practice. 2019; 3(2) |
|[Pubmed] | [DOI]|
||Immune Biomarkers for Diagnosis and Treatment Monitoring of Tuberculosis: Current Developments and Future Prospects
| ||Yean K. Yong,Hong Y. Tan,Alireza Saeidi,Won F. Wong,Ramachandran Vignesh,Vijayakumar Velu,Rajaraman Eri,Marie Larsson,Esaki M. Shankar |
| ||Frontiers in Microbiology. 2019; 10 |
|[Pubmed] | [DOI]|
||A Case of Fever of Unknown Origin Following Cardiac Arrest With Diagnosis Revealed on Autopsy
| ||Daisuke Furukawa,Owen McBride,Casey Kaneshiro,Jaime Betancourt |
| ||Infectious Diseases in Clinical Practice. 2018; 26(5): 297 |
|[Pubmed] | [DOI]|